Global Pharmaceutical Contract Development and Manufacturing Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Global Pharmaceutical Contract Development and Manufacturing Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

  • SKU :
    SAC8277359
  • Published Date :
    May 31, 2024
  • Number of Pages :
    350

Product Description

The Pharmaceutical Contract Development and Manufacturing market was valued at US$ xx in 2023. The market for Pharmaceutical Contract Development and Manufacturing is projected to grow from US$ xx million in 2024, and is projected to reach xx by 2031, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Pharmaceutical Contract Development and Manufacturing industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Pharmaceutical Contract Development and Manufacturing by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Pharmaceutical Contract Development and Manufacturing market are discussed.

The market is segmented by types: 
    Pharmaceutical Manufacturing Services
    Biologics Manufacturing Services
    Drug Development Services

It can be also divided by applications:
    Big Pharma
    Small Pharma
    Generic Pharma
    CRO

And this report covers the historical situation, present status and the future prospects of the global Pharmaceutical Contract Development and Manufacturing market for 2021-2031. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    Thermo Fisher Scientific Inc.
    Catalent, Inc.
    Lonza Group Ltd
    Recipharm AB
    Vetter Pharma International GMBH
    FAMAR Health Care Services
    AbbVie Inc.
    Aenova Group
    Consort Medical plc
    Almac Group
    Siegfried Holding AG
    Boehringer Ingelheim International GmbHÊ
    Evonik Industries AG

Report Includes:
- xx data tables and xx additional tables
- An overview of global Pharmaceutical Contract Development and Manufacturing market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2024 and projections of compound annual growth rates (CAGRs) through 2031
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Pharmaceutical Contract Development and Manufacturing market
- Profiles of major players in the industry, including     Thermo Fisher Scientific Inc.,     Catalent, Inc.,     Lonza Group Ltd,     Recipharm AB,     Vetter Pharma International GMBH.....

Research objectives
    To study and analyze the global Pharmaceutical Contract Development and Manufacturing consumption (value & volume) by key regions/countries, product type and application, history data from 2019 to 2021, and Forecast to 2031.
    To understand the structure of Pharmaceutical Contract Development and Manufacturing market by identifying its various subsegments.
    Focuses on the key global Pharmaceutical Contract Development and Manufacturing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Pharmaceutical Contract Development and Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Pharmaceutical Contract Development and Manufacturing submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content

Table of Contents

Global Pharmaceutical Contract Development and Manufacturing Market Report 2024, Forecast to 2031

1 Scope of the Study
    1.1 Pharmaceutical Contract Development and Manufacturing Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Pharmaceutical Contract Development and Manufacturing Industry Overview
    2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size (Million USD) Comparison by Regions (2024-2031)
        2.1.1 Pharmaceutical Contract Development and Manufacturing Global Import Market Analysis
        2.1.2 Pharmaceutical Contract Development and Manufacturing Global Export Market Analysis
        2.1.3 Pharmaceutical Contract Development and Manufacturing Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 Pharmaceutical Manufacturing Services
        2.2.2 Biologics Manufacturing Services
        2.2.3 Drug Development Services
    2.3 Market Analysis by Application
        2.3.1 Big Pharma
        2.3.2 Small Pharma
        2.3.3 Generic Pharma
        2.3.4 CRO
    2.4 Global Pharmaceutical Contract Development and Manufacturing Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Pharmaceutical Contract Development and Manufacturing Sales and Market Share by Manufacturer (2019-2023)
        2.4.2 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Manufacturer (2019-2023)
        2.4.3 Global Pharmaceutical Contract Development and Manufacturing Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Pharmaceutical Contract Development and Manufacturing Manufacturer Market Share
        2.4.5 Top 10 Pharmaceutical Contract Development and Manufacturing Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Pharmaceutical Contract Development and Manufacturing Market
        2.4.7 Key Manufacturers Pharmaceutical Contract Development and Manufacturing Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Pharmaceutical Contract Development and Manufacturing Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Pharmaceutical Contract Development and Manufacturing Industry Impact
        2.7.1 How the Covid-19 is Affecting the Pharmaceutical Contract Development and Manufacturing Industry
        2.7.2 Pharmaceutical Contract Development and Manufacturing Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Pharmaceutical Contract Development and Manufacturing Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 Pharmaceutical Contract Development and Manufacturing Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Pharmaceutical Contract Development and Manufacturing Market Size Categorized by Regions
    4.1 Global Pharmaceutical Contract Development and Manufacturing Revenue, Sales and Market Share by Regions
        4.1.1 Global Pharmaceutical Contract Development and Manufacturing Sales and Market Share by Regions (2019-2023)
        4.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Regions (2019-2023)
    4.2 Europe Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    4.3 APAC Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    4.4 North America Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    4.5 South America Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    4.6 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)

5 Europe Pharmaceutical Contract Development and Manufacturing Market Size Categorized by Countries
    5.1 Europe Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Countries
        5.1.1 Europe Pharmaceutical Contract Development and Manufacturing Sales by Countries (2019-2023)
        5.1.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2019-2023)
        5.1.3 Germany Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        5.1.4 UK Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        5.1.5 France Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        5.1.6 Russia Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        5.1.7 Italy Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        5.1.8 Spain Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    5.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue (Value) by Manufacturers (2019-2023)
    5.3 Europe Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Type (2019-2023)
        5.3.1 Europe Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2019-2023)
        5.3.2 Europe Pharmaceutical Contract Development and Manufacturing Revenue and Revenue Share by Type (2019-2023)
    5.4 Europe Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2019-2023)

6 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size Categorized by Countries
    6.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales by Countries (2019-2023)
        6.1.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2019-2023)
        6.1.3 China Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        6.1.4 Japan Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        6.1.5 Korea Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        6.1.6 India Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        6.1.7 Southeast Asia Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        6.1.8 Australia Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    6.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales and Revenue (Value) by Manufacturers (2019-2023)
    6.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Type (2019-2023)
        6.3.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2019-2023)
        6.3.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Revenue and Revenue Share by Type (2019-2023)
    6.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Sales and Market Share by Application (2019-2023)

7 North America Pharmaceutical Contract Development and Manufacturing Market Size Categorized by Countries
    7.1 North America Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Countries
        7.1.1 North America Pharmaceutical Contract Development and Manufacturing Sales by Countries (2019-2023)
        7.1.2 North America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2019-2023)
        7.1.3 United States Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        7.1.4 Canada Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        7.1.5 Mexico Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    7.2 North America Pharmaceutical Contract Development and Manufacturing Revenue (Value) by Manufacturers (2019-2023)
    7.3 North America Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Type (2019-2023)
        7.3.1 North America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2019-2023)
        7.3.2 North America Pharmaceutical Contract Development and Manufacturing Revenue and Revenue Share by Type (2019-2023)
    7.4 North America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2019-2023)

8 South America Pharmaceutical Contract Development and Manufacturing Market Size Categorized by Countries
    8.1 South America Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Countries
        8.1.1 South America Pharmaceutical Contract Development and Manufacturing Sales by Countries (2019-2023)
        8.1.2 South America Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2019-2023)
        8.1.3 Brazil Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    8.2 South America Pharmaceutical Contract Development and Manufacturing Revenue (Value) by Manufacturers (2019-2023)
    8.3 South America Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Type (2019-2023)
        8.3.1 South America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2019-2023)
        8.3.2 South America Pharmaceutical Contract Development and Manufacturing Revenue and Revenue Share by Type (2019-2023)
    8.4 South America Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2019-2023)

9 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Market Size Categorized by Countries
    9.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales by Countries (2019-2023)
        9.1.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue by Countries (2019-2023)
        9.1.3 GCC Countries Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        9.1.4 Turkey Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        9.1.5 Egypt Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
        9.1.6 South Africa Pharmaceutical Contract Development and Manufacturing Sales and Growth Rate (2019-2023)
    9.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue (Value) by Manufacturers (2019-2023)
    9.3 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales Market Share by Type (2019-2023)
        9.3.2 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Revenue and Revenue Share by Type (2019-2023)
    9.4 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Sales Market Share by Application (2019-2023)

10 Global Pharmaceutical Contract Development and Manufacturing Market Segment by Type
    10.1 Global Pharmaceutical Contract Development and Manufacturing Revenue, Sales and Market Share by Type (2019-2023)
        10.1.1 Global Pharmaceutical Contract Development and Manufacturing Sales and Market Share by Type (2019-2023)
        10.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue and Market Share by Type (2019-2023)
    10.2 Pharmaceutical Manufacturing Services Sales Growth Rate and Price
        10.2.1 Global Pharmaceutical Manufacturing Services Sales Growth Rate (2019-2023)
        10.2.2 Global Pharmaceutical Manufacturing Services Price (2019-2023)
    10.3 Biologics Manufacturing Services Sales Growth Rate and Price
        10.3.1 Global Biologics Manufacturing Services Sales Growth Rate (2019-2023)
        10.3.2 Global Biologics Manufacturing Services Price (2019-2023)
    10.4 Drug Development Services Sales Growth Rate and Price
        10.4.1 Global Drug Development Services Sales Growth Rate (2019-2023)
        10.4.2 Global Drug Development Services Price (2019-2023)

11 Global Pharmaceutical Contract Development and Manufacturing Market Segment by Application
    11.1 Global Pharmaceutical Contract Development and ManufacturingSales Market Share by Application (2019-2023)
    11.2 Big Pharma Sales Growth Rate (2019-2023)
    11.3 Small Pharma Sales Growth Rate (2019-2023)
    11.4 Generic Pharma Sales Growth Rate (2019-2023)
    11.5 CRO Sales Growth Rate (2019-2023)

12 Market Forecast for Pharmaceutical Contract Development and Manufacturing
    12.1 Global Pharmaceutical Contract Development and Manufacturing Revenue, Sales and Growth Rate (2024-2031)
    12.2 Pharmaceutical Contract Development and Manufacturing Market Forecast by Regions (2024-2031)
        12.2.1 Europe Pharmaceutical Contract Development and Manufacturing Market Forecast (2024-2031)
        12.2.2 APAC Pharmaceutical Contract Development and Manufacturing Market Forecast (2024-2031)
        12.2.3 North America Pharmaceutical Contract Development and Manufacturing Market Forecast (2024-2031)
        12.2.4 South America Pharmaceutical Contract Development and Manufacturing Market Forecast (2024-2031)
        12.2.5 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Forecast (2024-2031)
    12.3 Pharmaceutical Contract Development and Manufacturing Market Forecast by Type (2024-2031)
        12.3.1 Global Pharmaceutical Contract Development and Manufacturing Sales Forecast by Type (2024-2031)
        12.3.2 Global Pharmaceutical Contract Development and Manufacturing Market Share Forecast by Type (2024-2031)
    12.4 Pharmaceutical Contract Development and Manufacturing Market Forecast by Application (2024-2031)
        12.4.1 Global Pharmaceutical Contract Development and Manufacturing Sales Forecast by Application (2024-2031)
        12.4.2 Global Pharmaceutical Contract Development and Manufacturing Market Share Forecast by Application (2024-2031)

13 Analysis of Pharmaceutical Contract Development and Manufacturing Industry Key Manufacturers
    13.1 Thermo Fisher Scientific Inc.
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.1.4 Main Business Overview
        13.1.5 Thermo Fisher Scientific Inc. News
    13.2 Catalent, Inc.
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.2.4 Main Business Overview
        13.2.5 Catalent, Inc. News
    13.3 Lonza Group Ltd
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.3.4 Main Business Overview
        13.3.5 Lonza Group Ltd News
    13.4 Recipharm AB
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.4.4 Main Business Overview
        13.4.5 Recipharm AB News
    13.5 Vetter Pharma International GMBH
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.5.4 Main Business Overview
        13.5.5 Vetter Pharma International GMBH News
    13.6 FAMAR Health Care Services
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.6.4 Main Business Overview
        13.6.5 FAMAR Health Care Services News
    13.7 AbbVie Inc.
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.7.4 Main Business Overview
        13.7.5 AbbVie Inc. News
    13.8 Aenova Group
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.8.4 Main Business Overview
        13.8.5 Aenova Group News
    13.9 Consort Medical plc
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.9.4 Main Business Overview
        13.9.5 Consort Medical plc News
    13.10 Almac Group
        13.10.1 Company Details
        13.10.2 Product Information
        13.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.10.4 Main Business Overview
        13.10.5 Almac Group News
    13.11 Siegfried Holding AG
        13.11.1 Company Details
        13.11.2 Product Information
        13.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.11.4 Main Business Overview
        13.11.5 Siegfried Holding AG News
    13.12 Boehringer Ingelheim International GmbHÊ
        13.12.1 Company Details
        13.12.2 Product Information
        13.12.3 Boehringer Ingelheim International GmbHÊ Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.12.4 Main Business Overview
        13.12.5 Boehringer Ingelheim International GmbHÊ News
    13.13 Evonik Industries AG
        13.13.1 Company Details
        13.13.2 Product Information
        13.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Production, Price, Cost, Gross Margin, and Revenue (2019-2023)
        13.13.4 Main Business Overview
        13.13.5 Evonik Industries AG News

14 Research Findings and Conclusion

15 Appendix

Search results for Technology and Media Industry